Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very‐Low‐Density Lipoproteins

BACKGROUND: It is uncertain whether pharmacological reductions in very‐low‐density lipoproteins (VLDLs), and their component triglyceride and cholesterol could reduce residual risk of atherosclerotic cardiovascular disease (ASCVD) events among individuals in whom low‐density lipoprotein cholesterol...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawler, Patrick R., Akinkuolie, Akintunde O., Harada, Paulo, Glynn, Robert J., Chasman, Daniel I., Ridker, Paul M, Mora, Samia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779048/
https://www.ncbi.nlm.nih.gov/pubmed/29223956
http://dx.doi.org/10.1161/JAHA.117.007402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779048/
https://www.ncbi.nlm.nih.gov/pubmed/29223956
http://dx.doi.org/10.1161/JAHA.117.007402

Ejemplares similares